Clinical Guideline Highlights for the Hospitalist: 2019 American Thoracic Society/Infectious Diseases Society of America Update on Community-Acquired Pneumonia

Christopher D Jackson; Desirée C Burroughs-Ray; Nathan A Summers

doi:10.12788/jhm.3444

Clinical Guideline Highlights for the Hospitalist: 2019 American Thoracic Society/Infectious Diseases Society of America Update on Community-Acquired Pneumonia

J Hosp Med. 2020 Dec;15(12):743-745. doi: 10.12788/jhm.3444.

Authors

Christopher D Jackson¹, Desirée C Burroughs-Ray¹, Nathan A Summers²

Affiliations

¹ Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
² Division of Infectious Disease, Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.

PMID: 32853142
DOI: 10.12788/jhm.3444

Abstract

Diagnosis and Treatment of Adults with Community-Acquired Pneumonia: An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America RELEASE DATE: October 2019 PRIOR VERSION: 2007 Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults DEVELOPER: American Thoracic Society and Infectious Diseases Society of America FUNDING SOURCE: American Thoracic Society and Infectious Diseases Society of America TARGET POPULATION: Immunocompetent adult patients with community-acquired pneumonia.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anti-Bacterial Agents / therapeutic use
Communicable Diseases* / drug therapy
Community-Acquired Infections* / diagnosis
Community-Acquired Infections* / drug therapy
Hospitalists*
Humans
Pneumonia* / diagnosis
Pneumonia* / drug therapy
United States

Substances

Anti-Bacterial Agents